Teriflunomide: A Review of Its Use in Relapsing Multiple Sclerosis.
- Published in:
- CNS Drugs, 2013, v. 27, n. 12, p. 1103, doi. 10.1007/s40263-013-0118-2
- By:
- Publication type:
- Article
Works matching IS 11727047 AND DT 2013 AND VI 27 AND IP 12
Results: 10
1
2
Animal Migraine Models for Drug Development: Status and Future Perspectives.
- Published in:
- CNS Drugs, 2013, v. 27, n. 12, p. 1049, doi. 10.1007/s40263-013-0121-7
- By:
- Publication type:
- Article
3
Clinically Significant Drug Interactions with Atypical Antipsychotics.
- Published in:
- CNS Drugs, 2013, v. 27, n. 12, p. 1021, doi. 10.1007/s40263-013-0114-6
- By:
- Publication type:
- Article
4
Acknowledgement.
- Published in:
- CNS Drugs, 2013, v. 27, n. 12, p. 1003, doi. 10.1007/s40263-013-0122-6
- Publication type:
- Article
5
Erratum to: Systematic Review and Meta-Analysis of the Efficacy and Safety of Perampanel in the Treatment of Partial-Onset Epilepsy.
- Published in:
- 2013
- By:
- Publication type:
- Correction Notice
6
Novel Delivery Systems for Nicotine Replacement Therapy as an Aid to Smoking Cessation and for Harm Reduction: Rationale, and Evidence for Advantages over Existing Systems.
- Published in:
- CNS Drugs, 2013, v. 27, n. 12, p. 1007, doi. 10.1007/s40263-013-0116-4
- By:
- Publication type:
- Article
7
Lacosamide: A Review of Its Use as Adjunctive Therapy in the Management of Partial-Onset Seizures.
- Published in:
- CNS Drugs, 2013, v. 27, n. 12, p. 1125, doi. 10.1007/s40263-013-0123-5
- By:
- Publication type:
- Article
8
Scopolamine Detoxification Technique for Heroin Dependence: A Randomized Trial.
- Published in:
- CNS Drugs, 2013, v. 27, n. 12, p. 1093, doi. 10.1007/s40263-013-0111-9
- By:
- Publication type:
- Article
9
Second Generation Antipsychotic-Induced Type 2 Diabetes: A Role for the Muscarinic M3 Receptor.
- Published in:
- CNS Drugs, 2013, v. 27, n. 12, p. 1069, doi. 10.1007/s40263-013-0115-5
- By:
- Publication type:
- Article
10
Efficacy and Safety of Lisdexamfetamine Dimesylate and Atomoxetine in the Treatment of Attention-Deficit/Hyperactivity Disorder: a Head-to-Head, Randomized, Double-Blind, Phase IIIb Study.
- Published in:
- CNS Drugs, 2013, v. 27, n. 12, p. 1081, doi. 10.1007/s40263-013-0104-8
- By:
- Publication type:
- Article